The Pennsylvania Supreme Court issued a ruling on January 21, 2014 in the case of Lance v. Wyeth, 2014 Pa. LEXIS 205 (Pa. 2014), where a split Court found that drug companies are not immune to product liability claims in Pennsylvania for defective drugs. In a 56 page opinion that was upheld in a 4-2 ruling, the Court decided Lance some three years after oral argument and added to the uncertain future landscape of products liability law in Pennsylvania.
Posts tagged "pharmaceutical litigation"
Subscribe To This Blog's Feed
- Supreme Court of PA Holds That an Increase in UIM Coverage Requires Auto Insurers to Offer Opportunity to Waive Stacking
- Are Your Employment Policies Ambiguous? Third Circuit Case is a Reminder of the Value of Clear Wording
- Third Circuit Takes a Deep Dive Into the "Four Corners" Rule and Whether Faulty Work Constitutes an "Occurrence" in Sapa Extrusions, Inc. v Liberty Mutual Ins. Co.
- Uncharted Territory of Medical Marijuana and Employment Law in Pennsylvania Demonstrated by Police Officer's Administrative Leave